220 related articles for article (PubMed ID: 18409124)
1. [Acute renal failure - anticoagulation in continuous renal replacement therapy].
Hein OV; Birnbaum J; Spies C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):294-301; quiz 302. PubMed ID: 18409124
[TBL] [Abstract][Full Text] [Related]
2. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Steinfeldt T; Rolfes C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulation for renal replacement therapy: different methods to improve safety.
Oudemans-van Straaten HM; Fiaccadori E; Baldwin I
Contrib Nephrol; 2010; 165():251-262. PubMed ID: 20427976
[TBL] [Abstract][Full Text] [Related]
4. Regional citrate anticoagulation for continuous renal replacement therapy in children.
Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
[TBL] [Abstract][Full Text] [Related]
5. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
[TBL] [Abstract][Full Text] [Related]
6. Continuous venovenous hemofiltration without anticoagulation.
Uchino S; Fealy N; Baldwin I; Morimatsu H; Bellomo R
ASAIO J; 2004; 50(1):76-80. PubMed ID: 14763495
[TBL] [Abstract][Full Text] [Related]
7. Continuous venovenous hemofiltration with or without predilution regional citrate anticoagulation: a prospective study.
Nurmohamed SA; Vervloet MG; Girbes AR; Ter Wee PM; Groeneveld AB
Blood Purif; 2007; 25(4):316-23. PubMed ID: 17700015
[TBL] [Abstract][Full Text] [Related]
8. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients.
Kutsogiannis DJ; Gibney RT; Stollery D; Gao J
Kidney Int; 2005 Jun; 67(6):2361-7. PubMed ID: 15882280
[TBL] [Abstract][Full Text] [Related]
9. [Regional citrate anticoagulation during continuous hemofiltration in cardiosurgical patients].
Mukhoedova TV; Sokol'nikova TA
Anesteziol Reanimatol; 2010; (5):41-5. PubMed ID: 21395141
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.
Reeves JH; Cumming AR; Gallagher L; O'Brien JL; Santamaria JD
Crit Care Med; 1999 Oct; 27(10):2224-8. PubMed ID: 10548211
[TBL] [Abstract][Full Text] [Related]
11. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
Wu MY; Hsu YH; Bai CH; Lin YF; Wu CH; Tam KW
Am J Kidney Dis; 2012 Jun; 59(6):810-8. PubMed ID: 22226564
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: similar hemofilter survival but significantly less bleeding.
Betjes MG; van Oosterom D; van Agteren M; van de Wetering J
J Nephrol; 2007; 20(5):602-8. PubMed ID: 17918147
[TBL] [Abstract][Full Text] [Related]
13. Renal replacement therapy and anticoagulation.
Brandenburger T; Dimski T; Slowinski T; Kindgen-Milles D
Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):387-401. PubMed ID: 29248145
[TBL] [Abstract][Full Text] [Related]
14. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
[TBL] [Abstract][Full Text] [Related]
15. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.
Tan HK; Baldwin I; Bellomo R
Intensive Care Med; 2000 Nov; 26(11):1652-7. PubMed ID: 11193272
[TBL] [Abstract][Full Text] [Related]
16. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
17. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
Ryckelynck JP; Chouraqui D; Lobbedez T
Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of citrate anti-coagulation continuous renal replacement therapies in post-cardiac surgery patients with liver dysfunction.
De Vico P; Messino V; Tartaglione A; Beccaris C; Buonomo C; Talarico D; Prati P; Sabato AF; Colella DF
Ther Apher Dial; 2015 Jun; 19(3):272-8. PubMed ID: 25656632
[TBL] [Abstract][Full Text] [Related]
19. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy.
Kiser TH; MacLaren R; Fish DN; Hassell KL; Teitelbaum I
Pharmacotherapy; 2010 Nov; 30(11):1117-26. PubMed ID: 20973685
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the application of regional citrate anticoagulation in sustained low efficiency hemodialysis].
Wang T; Zhang L; Chen Z; Fu P
Zhonghua Nei Ke Za Zhi; 2014 Dec; 53(12):953-6. PubMed ID: 25623561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
